FDA inspection
Aspire Pharmaceuticals, Inc.: FDA inspection ending Jul 14, 2023
FDA inspection 1214674 · Voluntary Action Indicated (VAI) · Somerset, NJ
Key facts
| Inspection ID | 1214674 |
|---|---|
| Firm | Aspire Pharmaceuticals, Inc. |
| FEI number | 3003159106 |
| Address | 37 & 41 Veronica Ave |
| City | Somerset |
| State | NJ |
| ZIP | 08873 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jul 14, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Food Composition, Standards, Labeling and Econ |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data